Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Novel FujiLAM assay to detect tuberculosis in HIV-positive ambulatory patients in four African countries: a diagnostic accuracy study.
Huerga H, Bastard M, Lubega AV, Akinyi M, Antabak NT, Ohler L, Muyindike W, Taremwa IM, Stewart R, Bossard C, Nkosi N, Ndlovu Z, Hewison C, Stavia T, Okomo G, Ogoro JO, Ngozo J, Mbatha M, Aleny C, Wanjala S, Musoke M, Atwine D, Ascorra A, Ardizzoni E, Casenghi M, Ferlazzo G, Nakiyingi L, Gupta-Wright A, Bonnet M. Huerga H, et al. Among authors: ferlazzo g. Lancet Glob Health. 2023 Jan;11(1):e126-e135. doi: 10.1016/S2214-109X(22)00463-6. Lancet Glob Health. 2023. PMID: 36521944 Free PMC article.
Implementation and Operational Research: Feasibility of Using Tuberculin Skin Test Screening for Initiation of 36-Month Isoniazid Preventive Therapy in HIV-Infected Patients in Resource-Constrained Settings.
Huerga H, Mueller Y, Ferlazzo G, Mpala Q, Bevilacqua P, Vasquez B, Noël Mekiedje C, Ouattara A, Mchunu G, Weyenga HO, Varaine F, Bonnet M. Huerga H, et al. Among authors: ferlazzo g. J Acquir Immune Defic Syndr. 2016 Apr 1;71(4):e89-95. doi: 10.1097/QAI.0000000000000895. J Acquir Immune Defic Syndr. 2016. PMID: 26910386
Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study.
Ferlazzo G, Mohr E, Laxmeshwar C, Hewison C, Hughes J, Jonckheere S, Khachatryan N, De Avezedo V, Egazaryan L, Shroufi A, Kalon S, Cox H, Furin J, Isaakidis P. Ferlazzo G, et al. Lancet Infect Dis. 2018 May;18(5):536-544. doi: 10.1016/S1473-3099(18)30100-2. Epub 2018 Feb 13. Lancet Infect Dis. 2018. PMID: 29452942
TB screening, prevention and treatment cascade in a Malawi prison.
Mangochi P, Bossard C, Catacutan C, Van Laeken D, Kwitonda C, Ortuno R, Chiwaula L, Meis M, Abura A, Furin J, Mpunga J, Goemare E, Ellman T, Garone D, Ferlazzo G, Isaakidis P. Mangochi P, et al. Among authors: ferlazzo g. Int J Tuberc Lung Dis. 2022 Oct 1;26(10):956-962. doi: 10.5588/ijtld.22.0115. Int J Tuberc Lung Dis. 2022. PMID: 36163657
Clinical utility of target-based next-generation sequencing for drug-resistant TB.
Mansoor H, Hirani N, Chavan V, Das M, Sharma J, Bharati M, Oswal V, Iyer A, Morales M, Joshi A, Ferlazzo G, Isaakidis P, Ndlovu Z, England K. Mansoor H, et al. Among authors: ferlazzo g. Int J Tuberc Lung Dis. 2023 Jan 1;27(1):41-48. doi: 10.5588/ijtld.22.0138. Int J Tuberc Lung Dis. 2023. PMID: 36853141 Free PMC article.
188 results